167 related articles for article (PubMed ID: 31257327)
1. Study on Redox Properties and Cytotoxicity of Anthraquinone Derivatives to Understand Antitumor Active Anthracycline Substances.
Okumura N; Mizutani H; Ishihama T; Ito M; Hashibe A; Nakayama T; Uno B
Chem Pharm Bull (Tokyo); 2019; 67(7):717-720. PubMed ID: 31257327
[TBL] [Abstract][Full Text] [Related]
2. Novel anthraquinone derivatives with redox-active functional groups capable of producing free radicals by metabolism: are free radicals essential for cytotoxicity?
Barasch D; Zipori O; Ringel I; Ginsburg I; Samuni A; Katzhendler J
Eur J Med Chem; 1999; 34(7-8):597-615. PubMed ID: 11278045
[TBL] [Abstract][Full Text] [Related]
3. Enthalpy of oxygen addition to anthraquinone derivatives determines their ability to mediate NADH oxidation.
Jeziorek D; Dyl D; Liwo A; Ossowski T; Woźnicki W
Anticancer Drug Des; 1994 Oct; 9(5):435-48. PubMed ID: 7945727
[TBL] [Abstract][Full Text] [Related]
4. DNA-binding, DNA cleavage and cytotoxicity studies of two anthraquinone derivatives.
Gholivand MB; Kashanian S; Peyman H
Spectrochim Acta A Mol Biomol Spectrosc; 2012 Feb; 87():232-40. PubMed ID: 22192418
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic properties of the anthraquinone derivatives isolated from the roots of Rubia philippinensis.
Bajpai VK; Alam MB; Quan KT; Choi HJ; An H; Ju MK; Lee SH; Huh YS; Han YK; Na M
BMC Complement Altern Med; 2018 Jul; 18(1):200. PubMed ID: 29970094
[TBL] [Abstract][Full Text] [Related]
6. Voltammetric characterization of DNA intercalators across the full pH range: anthraquinone-2,6-disulfonate and anthraquinone-2-sulfonate.
Batchelor-McAuley C; Li Q; Dapin SM; Compton RG
J Phys Chem B; 2010 Mar; 114(11):4094-100. PubMed ID: 20196578
[TBL] [Abstract][Full Text] [Related]
7. Molecular modeling of singlet-oxygen binding to anthraquinones in relation to the peroxidating activity of antitumor anthraquinone drugs.
Liwo A; Jeziorek D; Ossowski T; Dyl D; Tempczyk A; Tarasiuk J; Nowacka M; Borowski E; Woźnicki W
Acta Biochim Pol; 1995; 42(4):445-56. PubMed ID: 8852335
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and cytotoxic effect of 1,3-dihydroxy-9,10-anthraquinone derivatives.
Wei BL; Wu SH; Chung MI; Won SJ; Lin CN
Eur J Med Chem; 2000 Dec; 35(12):1089-98. PubMed ID: 11248407
[TBL] [Abstract][Full Text] [Related]
9. Advances in the Discovery of Anthraquinone-Based Anticancer Agents.
Tikhomirov AS; Shtil AA; Shchekotikhin AE
Recent Pat Anticancer Drug Discov; 2018; 13(2):159-183. PubMed ID: 29210664
[TBL] [Abstract][Full Text] [Related]
10. Three novel members of angucycline group from Streptomyces sp. N05WA963.
Ren X; Lu X; Ke A; Zheng Z; Lin J; Hao W; Zhu J; Fan Y; Ding Y; Jiang Q; Zhang H
J Antibiot (Tokyo); 2011 Apr; 64(4):339-43. PubMed ID: 21285963
[TBL] [Abstract][Full Text] [Related]
11. Novel anthraquinone based chalcone analogues containing an imine fragment: synthesis, cytotoxicity and anti-angiogenic activity.
Kolundžija B; Marković V; Stanojković T; Joksović L; Matić I; Todorović N; Nikolić M; Joksović MD
Bioorg Med Chem Lett; 2014 Jan; 24(1):65-71. PubMed ID: 24332490
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of novel bis-anthraquinone derivatives and their biological evaluation as antitumor agents.
Taher AT; Hegazy GH
Arch Pharm Res; 2013 May; 36(5):573-8. PubMed ID: 23471561
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and cytotoxic effect of hydroxy- and 3-alkylaminopropoxy-9,10-anthraquinone derivatives.
Teng CH; Won SJ; Lin CN
Bioorg Med Chem; 2005 May; 13(10):3439-45. PubMed ID: 15848756
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and antiproliferative activity of 1,4-bis(dimethylamino)-9,10-anthraquinone derivatives against P388 mouse leukemic tumor cells.
Jin GZ; Jin HS; Jin LL
Arch Pharm Res; 2011 Jul; 34(7):1071-6. PubMed ID: 21811913
[TBL] [Abstract][Full Text] [Related]
15. Coccoquinones A and B, new anthraquinone derivatives produced by Staphylotrichum coccosporum PF1460.
Tatsuda D; Amemiya M; Sawa R; Sumiyoshi K; Watanabe T; Momose I; Kawada M; Nomoto A; Shibasaki M
J Antibiot (Tokyo); 2016 Mar; 69(3):176-8. PubMed ID: 26464010
[No Abstract] [Full Text] [Related]
16. Synthesis and cytotoxic evaluation of two novel anthraquinone derivatives.
Sadeghi-Aliabadi H; Tabarzadi M; Zarghi A
Farmaco; 2004 Aug; 59(8):645-9. PubMed ID: 15262534
[TBL] [Abstract][Full Text] [Related]
17. Effect of the aryl substituent on antitumor activity of 2-substituted-1,4-dihydroxy-9,10-anthraquinones and 2-substituted-anthracene-1,4,9,10-tetraones.
Nam NH; Jin GZ; Tam MN; Ahn BZ
Arch Pharm Res; 1999 Dec; 22(6):592-607. PubMed ID: 10615866
[TBL] [Abstract][Full Text] [Related]
18. Anthracyclinones from Micromonospora sp.
Sousa Tda S; Jimenez PC; Ferreira EG; Silveira ER; Braz-Filho R; Pessoa OD; Costa-Lotufo LV
J Nat Prod; 2012 Mar; 75(3):489-93. PubMed ID: 22250891
[TBL] [Abstract][Full Text] [Related]
19. Annulation of substituted anthracene-9,10-diones yields promising selectively antiproliferative compounds.
Castro-Castillo V; Suárez-Rozas C; Castro-Loiza N; Theoduloz C; Cassels BK
Eur J Med Chem; 2013 Apr; 62():688-92. PubMed ID: 23454511
[TBL] [Abstract][Full Text] [Related]
20. Heterocyclic ring expansion yields anthraquinone derivatives potent against multidrug resistant tumor cells.
Tikhomirov AS; Tsvetkov VB; Volodina YL; Litvinova VA; Andreeva DV; Dezhenkova LG; Kaluzhny DN; Treshalin ID; Shtil AA; Shchekotikhin AE
Bioorg Chem; 2022 Oct; 127():105925. PubMed ID: 35728293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
